WuXi Biologics (Cayman) I... (WXIBF)

PNK: WXIBF · Real-Time Price · USD

3.00

0.00 (0.00%)

At close: Apr 29, 2025, 3:47 PM

WuXi Biologics (Cayman) Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016
Cash & Equivalents	9.15B	9.67B	7.36B	6.4B	8.14B	9B	11.28B	7.1B	3.71B	6.21B	2.86B	4.08B	4.37B	503.88M	3.62B	169.1M
Short-Term Investments	340.08M	1.57B	1.34B	2.32B	1.73B	2.12B	2.66B	1.38B	1.67B	543M	164.99M	n/a	801K	1.56B	n/a	n/a
Long-Term Investments	2.81B	2.93B	1.42B	390.11M	701.53M	79.62M	-1.05B	-311.32M	-1.1B	-90.84M	191.47M	192.28M	84.88M	n/a	n/a	n/a
Other Long-Term Assets	700.37M	226.19M	1.51B	2.49B	1.93B	2.32B	2.82B	1.54B	1.73B	587.57M	621.92M	28.87M	17.89M	28.51M	n/a	n/a
Receivables	6.18B	6.18B	5.39B	5.16B	5.56B	3.27B	2.91B	2.37B	1.76B	1.38B	885.21M	798.88M	605.14M	314.3M	296.9M	293.87M
Inventory	1.96B	1.77B	1.97B	2.28B	2.14B	1.69B	1.71B	1.08B	611.76M	399.39M	318.95M	227.19M	243.34M	135.55M	91.59M	78.99M
Other Current Assets	2.15B	2B	1.82B	2.32B	3.09B	3.44B	3.42B	2.27B	1.66B	1.15B	771.05M	634.72M	609.87M	321.19M	185.87M	165.2M
Total Current Assets	19.82B	21.2B	17.88B	18.47B	20.66B	19.53B	21.98B	14.2B	9.41B	9.67B	5B	5.75B	5.83B	3.03B	4.34B	829.86M
Property-Plant & Equipment	30.78B	29.94B	28.99B	25.92B	21.85B	19.76B	17.74B	12.87B	10.04B	6.8B	4.04B	2.9B	2.17B	1.78B	1.29B	1.15B
Goodwill & Intangibles	2B	2.04B	2.07B	2.08B	2.09B	2.13B	1.92B	577.26M	590.96M	601.25M	322.02M	500.44M	465.31M	n/a	n/a	n/a
Total Long-Term Assets	36.29B	35.38B	34.26B	31.09B	26.82B	24.5B	21.6B	14.76B	11.31B	7.93B	5.2B	3.65B	2.75B	1.82B	1.3B	1.16B
Total Assets	56.11B	56.58B	52.14B	49.56B	47.47B	44.03B	43.58B	28.96B	20.72B	17.6B	10.21B	9.39B	8.58B	4.85B	5.64B	1.98B
Account Payables	874.53M	833.27M	573.2M	794.39M	995.33M	617.78M	534.61M	646M	355.38M	185.81M	250.7M	220.98M	142.24M	137.29M	85.54M	105.03M
Deferred Revenue	n/a	430.48M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	892.6M	576.33M	1.16B	1.32B	2.35B	2.12B	1.16B	767.13M	745.92M	506.11M	n/a	n/a	n/a	n/a	313.16M	222.42M
Other Current Liabilities	3.93B	4.84B	5.37B	6.06B	5.07B	4.56B	3.17B	2.49B	1.79B	1.89B	946.3M	952.34M	757.38M	572.15M	415.82M	403.25M
Total Current Liabilities	6.81B	7.64B	8.14B	9.32B	9B	8.26B	5.44B	4.5B	3.17B	2.87B	1.35B	1.32B	990.17M	798.07M	865.09M	800.83M
Long-Term Debt	1.26B	1.57B	1.66B	1.46B	531.9M	640.51M	2.07B	1.84B	2.2B	1.4B	n/a	n/a	n/a	n/a	896M	866M
Other Long-Term Liabilities	1.17B	n/a	n/a	n/a	n/a	n/a	1.25B	1.06B	735.5M	n/a	68K	80.17M	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	4.66B	4.92B	4.96B	4.03B	3B	3.07B	4.56B	3.57B	3.77B	1.83B	319.13M	80.17M	69.03M	26.53M	944.68M	913.7M
Total Liabilities	11.46B	12.56B	13.1B	13.35B	11.99B	11.33B	10B	8.06B	6.95B	4.71B	1.67B	1.4B	1.06B	824.6M	1.81B	1.71B
Total Debt	4.57B	4.56B	5.14B	4.42B	4.4B	4.3B	4.6B	3.33B	3.68B	2.19B	248.05M	n/a	n/a	n/a	1.24B	1.13B
Common Stock	228K	235K	234K	233K	235K	235K	234K	225K	216K	214K	204K	202K	201K	192K	192K	158K
Retained Earnings	n/a	13.49B	12.78B	11.58B	9.69B	7.16B	5.61B	3.77B	2.82B	1.88B	1.41B	962.23M	636.21M	394.24M	257.73M	165.53M
Comprehensive Income	40.65B	1.78B	37.74B	1.37B	712.48M	593.13M	633.19M	845.18M	478.33M	-829.2M	348.8M	-556.77M	189.56M	-349.24M	107.42M	-227.17M
Shareholders Equity	40.66B	40.33B	37.74B	35.05B	34.46B	32.28B	33.22B	20.56B	13.63B	12.78B	8.54B	7.99B	7.52B	4.02B	3.83B	270.47M
Total Investments	3.15B	2.93B	2.76B	2.71B	2.43B	2.2B	1.61B	1.07B	561.27M	452.16M	356.47M	192.28M	85.69M	1.56B	n/a	n/a